Proliferation of TSU-Pr1, a human prostatic carcinoma cell line is stimulated by gonadotropin-releasing hormone

Life Sciences

Volumn 74, Issue 25, 2004, Pages 3141-3152

  Enomoto, Masahiro ^a   Seong, Jae Young ^b   Kawashima, Seiichiro ^c   Park, Min Kyun ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Chonnam National University   (South Korea)

^c ZENYAKU KOGYO CO LTD   (Japan)

Author keywords

Cell proliferation; Conditioned medium; GnRH; Prostatic carcinoma; TSU Pr1 cell line

Indexed keywords

GONADORELIN; GONADORELIN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL PROLIFERATION; CELL STIMULATION; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; HORMONE ACTION; HUMAN; HUMAN CELL; MALE; PROSTATE CARCINOMA; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL DIVISION; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA, CONDITIONED; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; PROSTATIC NEOPLASMS; RECEPTORS, LHRH; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 1842662407     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.11.009     Document Type: Article

References (53)

1. Andreis P.G., Neri G., Nussdorfer G.G. Effect of luteinizing hormone-releasing hormone on rat adrenocortical cells. Journal of Steroid Biochemistry and Molecular Biology. 63:1997;17-19.
2. Arencibia J.M., Schally A.V. Luteinizing hormone-releasing hormone as an autocrine growth factor in ES-2 ovarian cancer cell line. International Journal of Oncology. 16:2000;1009-1013.
3. Ataya K.M., Sakr W., Blacker C.M., Mutchnick M.G., Latif Z.A. Effect of GnRH agonists on the thymus in female rats. Acta Endocrinologica (Copenhagen). 121:1989;833-840.
4. Azad N., LaPaglia N., Kirsteins L., Uddin S., Steiner J., Williams D.W., Lawrence A.M., Emanuele N.V. Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormone. Journal of Endocrinology. 153:1997;241-249.
5. Batticane N., Morale M.C., Gallo F., Farinella Z., Marchetti B. Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. Endocrinology. 129:1991;277-286.
6. Belisle S., Guevin J.F., Bellabarba D., Lehoux J.G. Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin. Journal of Clinical Endocrinology and Metabolism. 59:1984;119-126.
7. Billig H., Furuta I., Hsueh A.J. Gonadotropin-releasing hormone directly induces apoptotic cell death in the rat ovary: biochemical and in situ detection of deoxyribonucleic acid fragmentation in granulosa cells. Endocrinology. 134:1994;245-252.
8. Blacker C.M., Ataya K.M., Savoy Moore R.T., Subramanian M.G., Mutchnick M.G., Dunbar J.C. The gonadotropin-releasing hormone agonist leuprolide affects the thymus and other non-reproductive systems of female rats. Acta Endocrinologica (Copenhagen). 125:1991;581-589.
9. Bourne G.A., Regiani S., Payne A.H., Marshall J.C. Testicular GnRH receptors-characterization and localization on interstitial tissue. Journal of Clinical Endocrinology and Metabolism. 51:1980;407-409.
10. Clayton R.N., Harwood J.P., Catt K.J. Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production. Nature. 282:1979;90-92.
11. Clayton R.N., Katikineni M., Chan V., Dufau M.L., Catt K.J. Direct inhibition of testicular function by gonadotropin-releasing hormone: mediation by specific gonadotropin-releasing hormone receptors in interstitial cells. Proceedings of the National Academy of Sciences of the United States of America. 77:1980;4459-4463.
12. Dondi D., Moretti R.M., Montagnani Marelli M., Pratesi G., Polizzi D., Milani M., Motta M., Limonta P. Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice. International Journal of Cancer. 76:1998;506-511.
13. Durmaz R., Deliorman S., Isiksoy S., Uyar R., Tel E. Luteinizing hormone releasing hormone increases proliferation of meningioma cells in vitro. Archives of Physiology and Biochemistry. 107:1999;286-291.
14. Eisthen H.L., Delay R.J., Wirsig Wiechmann C.R., Dionne V.E. Neuromodulatory effects of gonadotropin releasing hormone on olfactory receptor neurons. Journal of Neuroscience. 20:2000;3947-3955.
15. Emons G., Schroder B., Ortmann O., Westphalen S., Schulz K.D., Schally A.V. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines. Journal of Clinical Endocrinology and Metabolism. 77:1993;1458-1464.
16. Enomoto M., Mori T., Park M.K. GnRH agonist Buserelin affects colony-forming efficiency of HHUA and Jurkat cells. Biochemical and Biophysical Research Communications. 289:2001;1180-1187.
17. Enomoto M., Mori T., Park M.K. Influence of serum supplements in culture medium on gonadotropin-releasing hormone effects on colony formation. Life Sciences. 71:2002;2153-2160.
18. Gillis S., Watson J. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. Journal of Experimental Medicine. 152:1980;1709-1719.
19. Gründker C., Volker P., Schultz K.D., Emons G. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers. Gynecological Oncology. 78:2000;194-202.
20. Gründker C., Schultz K., Gunthert A.R., Emons G. Luteinizing hormone-releasing hormone induces nuclear factor kappaB-activation and inhibits apoptosis in ovarian cancer cells. Journal of Clinical Endocrinology and Metabolism. 85:2000;3815-3820.
21. Gründker C., Volker P., Emons G. Antiproliferative signaling of luteinizing hormone-releasing hormone in human endometrial and ovarian cancer cells through G protein alpha(I)-mediated activation of phosphotyrosine phosphatase. Endocrinology. 142:2001;2369-2380.
22. Gründker C., Schlotawa L., Viereck V., Emons G. Protein kinase C-independent stimulation of activator potein-1 and c-Jun N-terminal kinase activity in human encometrial cancer cells by LHRH agonist triptorelin. European Journal of Endocrinology. 145:2001;651-658.
23. Gründker C., Gunthert A.R., Millar R.P., Emons G. Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. Journal of Clinical Endocrinology and Metabolism. 87:2002;1427-1430.
24. Gunthert A.R., Gründker C., Hollmann K., Emons G. Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells. Biochemical and Biophysical Research Communications. 294:2002;11-15.
25. Iizumi T., Yazaki T., Kanoh S., Kondo I., Koiso K. Establishment of a new prostatic carcinoma cell line (TSU-Pr1). Journal of Urology. 137:1987;1304-1306.
26. Ishiwata I., Ishiwata C., Soma M., Arai J., Ishikawa H. Establishment of human endometrial adenocarcinoma cell line containing estradiol-17 beta and progesterone receptors. Gynecologic Oncology. 17:1984;281-290.
27. Iwashita M., Evans M.I., Catt K.J. Characterization of a gonadotropin-releasing hormone receptor site in term placenta and chorionic villi. Journal of Clinical Endocrinology and Metabolism. 62:1986;127-133.
28. Jungwirth A., Galvan G., Pinski J., Halmos G., Szepeshazi K., Cai R.Z., Groot K., Schally A.V. Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice. Prostate. 32:1997;164-172.
29. Kleinman D., Douvdevani A., Schally A.V., Levy J., Sharoni Y. Direct growth inhibition of human endometrial cancer cells by the gonadotropin- releasing hormone antagonist SB-75: role of apoptosis. American Journal of Obstetrics and Gynecology. 170:1994;96-102.
30. Knecht M., Ranta T., Feng P., Shinohara O., Catt K.J. Gonadotropin-releasing hormone as a modulator of ovarian function. Journal of Steroid Biochemistry. 23:1985;771-778.
31. Kogo H., Kudo A., Park M.K., Mori T., Kawashima S. In situ detection of gonadotropin-releasing hormone (GnRH) receptor mRNA expression in the rat ovarian follicles. Journal of Experimental Zoology. 272:1995;62-68.
32. Kogo H., Fujimoto T., Park M.K., Mori T. Gonadotropin-releasing hormone receptor mRNA expression in the ovaries of neonatal and adult rats. Cells, Tissues, Organs. 164:1999;14-22.
33. Koppan M., Nagy A., Schally A.V., Plonowski A., Halmos G., Arencibia J.M., Groot K. Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice. Prostate. 38:1999;151-158.
34. Maier C.C., Marchetti B., LeBoeuf R.D., Blalock J.E. Thymocytes express a mRNA that is identical to hypothalamic luteinizing hormone-releasing hormone mRNA. Cellular and Molecular Neurobiology. 12:1992;447-454.
35. Marchetti B., Guarcello V., Morale M.C., Bartoloni G., Farinella Z., Cordaro S., Scapagnini U. Luteinizing hormone-releasing hormone-binding sites in the rat thymus: characteristics and biological function. Endocrinology. 125:1989;1025-1036.
36. Marchetti B., Guarcello V., Morale M.C., Bartoloni G., Raiti F., Palumbo G. Jr., Farinella Z., Cordaro S., Scapagnini U. Luteinizing hormone-releasing hormone (LHRH) agonist restoration of age-associated decline of thymus weight, thymic LHRH receptors, and thymocyte proliferative capacity. Endocrinology. 125:1989;1037-1045.
37. Marchetti B., Guarcello V., Morale M.C., Bartoloni G., Palumbo G. Jr., Raiti F., Cutuli N., Farinella Z., Scapagnini U. A physiological role for the neuropeptide luteinizing hormone-releasing hormone (LHRH) during the maturation of thymus gland function. International Journal of Neuroscience. 51:1990;287-289.
38. Miller W.R., Scott W.N., Morris R., Fraser H.M., Sharpe R.M. Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist. Nature. 313:1985;231-233.
39. Oka Y. Physiology and release activity of GnRH neurons. Progress in Brain Research. 141:2002;259-281.
40. Pati D., Habibi H.R. Inhibition of human hepatocarcinoma cell proliferation by mammalian and fish gonadotropin-releasing hormones. Endocrinology. 136:1995;75-84.
41. Plonowski A., Schally A.V., Nagy A., Groot K., Krupa M., Navone N.M., Logothetis C. Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207. Cancer Letters. 176:2002;57-63.
42. Radulovic S., Comaru Schally A.M., Milovanovic S., Schally A.V. Somatostatin analogue RC-160 and LH-RH antagonist SB-75 inhibit growth of MIA PaCa-2 human pancreatic cancer xenografts in nude mice. Pancreas. 8:1993;88-97.
43. Redding T.W., Schally A.V. Inhibition of mammary tumor growth in rats and mice by administration of agonistic and antagonistic analogs of luteinizing hormone-releasing hormone. Proceedings of the National Academy of Sciences of the United States of America. 80:1983;1459-1462.
44. Rosa-e-Silva A.A., Lamano Carvalho T.L., Queiroz A.N. Effect of an LH-RH analog on cat testis and adrenal cortex function. Brazilian Journal of Medical and Biological Research. 24:1991;1107-1111.
45. Schally A.V., Redding T.W., Comaru Schally A.M. Inhibition of prostate tumors by agonistic and antagonistic analogs of LH-RH. Prostate. 4:1983;545-552.
46. Schally A.V. Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis. Peptides. 20:1999;1247-1262.
47. Schally A.V. LH-RH analogues: I. Their impact on reproductive medicine. Gynecological Endocrinology. 13:1999;401-409.
48. Schally A.V., Comaru Schally A.M., Plonowski A., Nagy A., Halmos G., Rekasi Z. Peptide analogs in the therapy of prostate cancer. Prostate. 45:2000;158-166.
49. Schally A.V., Nagy A. New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin. Life Sciences. 72:2003;2305-2320.
50. Sugiyama M., Imai A., Takahashi S., Hirano S., Furui T., Tamaya T. Advanced indications for gonadotropin-releasing hormone (GnRH) analogues in gynecological oncology (Review). International Journal of Oncology. 23:2003;445-452.
51. Szende B., Zalatnai A., Schally A.V. Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin. Proceedings of the National Academy of Sciences of the United States of America. 86:1989;1643-1647.
52. Templeton H. The management of prostate cancer. Nursing Standard. 17:2003;45-53. (quiz 54-5).
53. Wells A., Souto J.C., Solava J., Kassis J., Bailey K.J., Turner T. Luteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signaling. Clinical Cancer Research. 8:2002;1251-1257.